Daily Archives: April 7, 2021
RCT: Celecoxib for 3 years added to standard adjuvant therapy does not improve disease-free survival among patients with stage III colon cancer
7 Apr, 2021 | 01:28h | UTCEffect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Celecoxib for Stage III Colon Cancer – JAMA (free for a limited period)
RCT: Among patients with peripheral artery disease, low-intensity exercise was significantly less effective than high-intensity exercise for improving 6-minute walk distance
7 Apr, 2021 | 01:31h | UTCEffect of Low-Intensity vs High-Intensity Home-Based Walking Exercise on Walk Distance in Patients With Peripheral Artery Disease: The LITE Randomized Clinical Trial – JAMA (free for a limited period)
Commentary on Twitter
In this RCT of patients with PAD, low-intensity home-based exercise was less effective than high-intensity home-based exercise, and similar to the nonexercise control, for improving 6-min walk distance https://t.co/dVWCDx5hLM @NUFeinbergMed @StanfordMed @UChicagoMed @wakehealth
— JAMA (@JAMA_current) April 6, 2021
Short review | Assessment and management of dysphagia and achalasia
7 Apr, 2021 | 01:13h | UTCAssessment and management of dysphagia and achalasia – Clinical Medicine Journal
Commentary on Twitter
Diagnostic approach to dysphagia and achalasia
? in this month’s @Clin_Med https://t.co/LDe7lI1Ruc pic.twitter.com/nnK09HBy8Z
— Keith Siau (@drkeithsiau) March 27, 2021
A method for tapering antipsychotic treatment that may minimize the risk of relapse
7 Apr, 2021 | 01:25h | UTC
Commentary on Twitter (thread – click for more)
(Thread) Today we have published a paper on a way to reduce antipsychotics to minimise withdrawal effects and possibly relapse in @SchizBulletin. https://t.co/rbsBQLIuni with thanks to co-authors Robin Murray, David Taylor, @sameerjauhar and Sridhar Natesan. (1/n)
— Mark Horowitz (@markhoro) March 23, 2021
Consensus Document: Management of the complications of long term indwelling catheters
7 Apr, 2021 | 01:20h | UTC
CDC Updated Guidance: “It is possible for people to be infected through contact with contaminated surfaces or objects, but the risk is generally considered to be low”
7 Apr, 2021 | 02:00h | UTCRelated: Catching COVID from surfaces is very unlikely. So perhaps we can ease up on the disinfecting – The Conversation AND Coronavirus is in the air — there’s too much focus on surfaces – Nature AND COVID-19 rarely spreads through surfaces. So why are we still deep cleaning? – Nature
M-A: Antenatal corticosteroids for impending late preterm (34-36+6 weeks) deliveries
7 Apr, 2021 | 01:22h | UTC
Identifying and managing functional cardiac symptoms
7 Apr, 2021 | 01:15h | UTCIdentifying and managing functional cardiac symptoms – Clinical Medicine Journal
Practical Guide: Perioperative Pain Management and Opioid Stewardship
7 Apr, 2021 | 01:17h | UTCPerioperative Pain Management and Opioid Stewardship: A Practical Guide – Healthcare
Cohort study: Risk of suicide attempt in patients with recent diagnosis of mild cognitive impairment or dementia
7 Apr, 2021 | 01:08h | UTCRisk of Suicide Attempt in Patients With Recent Diagnosis of Mild Cognitive Impairment or Dementia – JAMA Psychiatry (link to abstract – $ for full-text)
Commentaries: Recent Diagnosis of Cognitive Impairment, Dementia May Increase Suicide Risk – Psychiatric News Alert AND Suicide Attempts Spike Soon After Dementia Diagnosis – HealthDay
Systematic review: Selective serotonin re‐uptake inhibitors for premature ejaculation in adult men
7 Apr, 2021 | 01:10h | UTCSelective serotonin re‐uptake inhibitors for premature ejaculation in adult men – Cochrane Library
Differences in susceptibility of circulating SARS-CoV-2 variants B.1.1.7 and B.1.351 to neutralization by convalescent plasma or vaccinee (Sinopharm or Sinovac) serum
7 Apr, 2021 | 01:57h | UTCRelated studies: Another study indicates SARS-CoV-2 variant B.1.351, but not variant B.1.1.7, has partial resistance to neutralizing antibodies generated by natural infection or mRNA vaccination – Nature Medicine AND Pfizer coronavirus vaccine found to be moderately less effective against B.1.351 variant AND SARS-CoV-2 variants B.1.351 and P.1 can escape from therapeutic antibodies and evade antibodies induced by infection or mRNA vaccination AND B.1.351 strain of SARS-CoV-2 neutralization titer reduced 8- to 9-fold for Pfizer and AstraZeneca vaccinees. Convalescent plasma and therapeutic antibodies were less effective against this variant as well. AND RCT: Oxford/AstraZeneca vaccine does not protect against mild-to-moderate Covid-19 due to the B.1.351 variant AND New study of Coronavirus variants predicts virus evolving to escape current vaccines, treatments AND Moderna COVID-19 vaccine may be less effective against variant found in South Africa
Commentary on Twitter
Lab study on vaxes & variants, testing blood samples: Sinopharm's Beijing vax & Sinovac's CoronaVac (1st study). Both held up reasonably with B.1.1.7 ("UK") variant of concern; both found B.1.351 ("SA") challenging https://t.co/X10ZnpSsrZ
40 of these now: https://t.co/Kwo742xWBm— Hilda Bastian, PhD (@hildabast) April 7, 2021
Guidance on syndrome of Thrombosis and Thrombocytopenia occurring after coronavirus Vaccination
7 Apr, 2021 | 01:48h | UTC
Commentary on Twitter
*CLINICIANS*
New guidance for suspected cases of thrombosis-thrombocytopaenia syndrome following COVID-19 vaccination. This is a very rare event but worth bookmarking as it also guides you on what is NOT likely to be a case.MT @Maherjane https://t.co/PHjFlB079y
— Trisha Greenhalgh ? #CovidIsAirborne (@trishgreenhalgh) April 6, 2021
Epidemiology of Multisystem Inflammatory Syndrome in Children: A Step Closer to Understanding Who, Where, and When
7 Apr, 2021 | 01:52h | UTCCommentaries: New findings in COVID-related kids’ syndrome, Kawasaki disease – CIDRAP AND Most kids with serious inflammatory illness had mild COVID – Associated Press
Opinion | New COVID variants have changed the game, and vaccines will not be enough. We need global ‘maximum suppression’
7 Apr, 2021 | 01:44h | UTC
Commentary on Twitter
✨"COVID-19 variants of concern have changed the game. We need to recognise and act on this if we as a global society are to avoid future waves of infections, yet more lockdowns and restrictions, and avoidable illness and death"✨ https://t.co/YXzqayMQFR
— Antibiotic Steward??Bassam Ghanem (@ABsteward) April 6, 2021
Antibody persistence for at least 6 months after the second dose of mRNA vaccine (Moderna) for Covid-19
7 Apr, 2021 | 01:54h | UTCCommentary: Moderna COVID Vaccine Offers Protection for at Least 6 Months: Study – HealthDay
Related: [Press release – not published yet] Pfizer/BioNTech vaccine is 91% effective for at least 6 months
Commentary on Twitter
Very good neutralizing antibody levels for at least 7 months after 2 doses of mRNA vaccine (and likely years)@NEJM today https://t.co/3KQmiuvEJq pic.twitter.com/cp2htnr76E
— Eric Topol (@EricTopol) April 6, 2021
What’s the new coronavirus variant in India and how should it change their COVID response?
7 Apr, 2021 | 01:42h | UTC
Covid-19: Italy makes vaccination mandatory for healthcare workers
7 Apr, 2021 | 01:39h | UTCCovid-19: Italy makes vaccination mandatory for healthcare workers – The BMJ
Large study showed no association between blood group types and increased risk of Covid-19
7 Apr, 2021 | 01:41h | UTC
Commentary on Twitter
This case-control study found blood type A was not associated with higher nor type O with lower COVID-19 susceptibility or severity. Blood types were not prognostically useful. https://t.co/P8VpvQWuwE
— JAMA Network Open (@JAMANetworkOpen) April 6, 2021